Bionomics Ltd (External organisation)

  • Jonathan Bayldon Baell (Inventor)
  • Brad Sleebs (Inventor)
  • Flynn, B. L. (Inventor)
  • Ian Philip Street (Inventor)
  • Nurul Quazi (Inventor)
  • Chinh Thien Bui (Inventor)

Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent

Description

Novel anxiolytic compounds

Abstract: The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders

WO2008046135A1 - WIPO (PCT)
Application PCT/AU2007/001566 events
2006-10-16 Priority to US85198306P
2006-10-16 Priority to US60/851,983
2007-10-16 Application filed by Bionomics Limited
2008-04-24 Publication of WO2008046135A1
2017-12-15 Priority claimed from US15/844,264

Related patent documents
CA2954376 US20090067848 EP2074123 US20100105678 EP2540722 ES2399071 AU2007312936 DK2074123 PT2074123 JP2010506829 PL2074123 NZ576036 CA2666219 US20130012508 US20130012509 AU2013202426 JP2013189453 US20140045839 US20150166534 JP2015155444 US20170183347 JP2017105818 US20180105523 US20180105524

Period2008
Held atBionomics Ltd, Australia, South Australia
Degree of RecognitionInternational

Documents & Links